You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 1, 2024

Vorapaxar sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for vorapaxar sulfate and what is the scope of patent protection?

Vorapaxar sulfate is the generic ingredient in one branded drug marketed by Xspire Pharma and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorapaxar sulfate has one hundred and sixty-four patent family members in thirty-seven countries.

Summary for vorapaxar sulfate
International Patents:164
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 1
Patent Applications: 19
DailyMed Link:vorapaxar sulfate at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for vorapaxar sulfate
Generic Entry Date for vorapaxar sulfate*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for vorapaxar sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ken MahaffeyPhase 2
Merck Sharp & Dohme Corp.Phase 2
Matthew MellPhase 2

See all vorapaxar sulfate clinical trials

US Patents and Regulatory Information for vorapaxar sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xspire Pharma ZONTIVITY vorapaxar sulfate TABLET;ORAL 204886-001 May 8, 2014 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
Xspire Pharma ZONTIVITY vorapaxar sulfate TABLET;ORAL 204886-001 May 8, 2014 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for vorapaxar sulfate

Country Patent Number Title Estimated Expiration
Canada 2410177 ANTAGONISTES DU RECEPTEUR DE LA THROMBINE (THROMBIN RECEPTOR ANTAGONISTS) ⤷  Try a Trial
Ecuador SP045368 "ANTAGONISTAS DE LOS RECEPTORES DE TROMBINA" ⤷  Try a Trial
Poland 359822 Antagoniści receptora trombiny (THROMBIN RECEPTOR ANTAGONISTS) ⤷  Try a Trial
Taiwan 200526643 Methods of use of thrombin receptor antagonists ⤷  Try a Trial
China 1436185 Thrombin receptor antagonists ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for vorapaxar sulfate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1495018 132016000023030 Italy ⤷  Try a Trial PRODUCT NAME: VORAPAXAR, O UN SUO SALE O SOLVATO FARMACEUTICAMENTE ACCETTABILE(ZONTIVITY); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/976, 20150119
1495018 C20150025 00159 Estonia ⤷  Try a Trial PRODUCT NAME: VORAPAKSAAR;REG NO/DATE: EU/1/14/976 21.01.2015
1495018 1590037-6 Sweden ⤷  Try a Trial PRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/14/976/001 20150121
1495018 C300746 Netherlands ⤷  Try a Trial PRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
1495018 S1500036 Hungary ⤷  Try a Trial PRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.